June 05, 2020
Video
Head of Global Clinical Development in Neurology at EMD Serono discussed the findings of a phase 2 assessment of the company’s investigational BTK inhibitor evobrutinib in multiple sclerosis.
October 12, 2018
Video
The Head of Global Clinical Development in Neurology at EMD Serono provided insight into the therapy's performance in phase IIb.